FDA delays decision on Agios drug in thalassemia over liver safety

The FDA pushed back its decision date by three months for Agios Pharmaceuticals’ drug Pyrukynd in thalassemia, the Cambridge, MA-based company announced Thursday morning. The agency’s decision was expected by Sept ...